The influence of Isoflurane versus combined isoflurane - epidural anesthesia on the immune response in patients undergoing surgery for colorectal canc
Not Applicable
Recruiting
- Conditions
- CancerSurgeryAnaesthesia
- Registration Number
- PACTR201604001580272
- Lead Sponsor
- Mohamed M Abu Elyazed
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
above the age of 18 years,
ASA I-II
undergoing elective undergoing elective surgical intervention for colorectal cancer
Exclusion Criteria
1- Emergency surgery
2- Renal dysfunction
3- Hepatic dysfunction
4- Cardiovascular diseases
5- Diabetes mellitus
6- Contraindications of epidural analgesia
7- Recent intake of corticosteroids or nonsteroidalantiinflammatory medications
8- Recent history of radiotherapy or chemotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie isoflurane's impact on immune response in colorectal cancer surgery?
How does combined isoflurane-epidural anesthesia compare to standard general anesthesia in colorectal cancer outcomes?
Which immune biomarkers predict differential response to isoflurane versus epidural anesthesia in oncologic surgery?
What are the potential adverse events associated with epidural anesthesia in colorectal cancer patients under isoflurane?
Are there alternative anesthetic combinations that modulate immune response more effectively than isoflurane-epidural in colorectal cancer surgery?